# Jasper Therapeutics, Inc.: Form 8-K, filed Oct 29, 2021

- Company: [Jasper Therapeutics, Inc.](/companies/jspr.md) (CIK 1788028)
- Form: 8-K
- Filed: 2021-10-29
- Accepted by EDGAR: Oct 29, 2021, 16:10 ET
- Period: 2021-10-25
- Accession: 0001213900-21-055431
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1788028/000121390021055431/ea149564-8k_jaspertherap.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1788028/000121390021055431/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1788028/000121390021055431/ea149564-8k_jaspertherap.htm

Filed Oct 29, 2021.
Source: SEC EDGAR, the filing index for accession 0001213900-21-055431. Last ingested by Listed: Nov 14, 2026, 21:17 ET. No prices; not investment advice.
